Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYC associated factor X, pseudogene" is a non-protein-coding genomic locus related to the MAX gene. Unlike the functional **MYC associated factor X (MAX)**, which encodes a basic helix-loop-helix leucine zipper (bHLHZ) transcription factor that functions as a dimerization partner for MYC and other related proteins in the regulation of cell proliferation and apoptosis[1][10], the pseudogene does not produce a functional protein and has no recognized biological or pharmacological function. Pseudogenes are generally regarded as non-functional remnants of genes that have lost their protein-coding ability. Thus, this entry is not suitable as a drug target or as a source of biomarker or mechanism-of-action data. Key notes: - The **functional gene** is "MYC associated factor X (MAX)"[10]. - The **pseudogene** (ENSG00000271414) should not be treated as a functional therapeutic target. - Any references to function, disease role, or drug interactions pertain to the protein-coding gene, not the pseudogene. For the proper target (MAX), see information under gene symbol **MAX**, not ENSG00000271414.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MYC associated factor X, pseudogene.